mRNA-4157 / V940 + Anti-PD1

Neoantigen Cancer Vaccine & Checkpoint Simulator

Microenvironment Arena: Dendritic Priming → Clonal TCR → Tumor Lysis PHASE: PRIMING & EXPANSION
Tumor Burden
120 cells
Primed CD8+ Clones
840 / μL
Checkpoint Inhibition
94%
Tumor Clearance
96.5%
Enjoy this tool? Build your own with Super